Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000217936 | SCV000273290 | likely benign | Hereditary cancer-predisposing syndrome | 2019-02-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000031425 | SCV000488148 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-02-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001703437 | SCV000512355 | likely benign | not provided | 2018-12-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 18824701, 15983021, 19491284, 18951461, 24817641, 21990165, 10923033, 30212499) |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000440300 | SCV000600554 | uncertain significance | not specified | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000217936 | SCV000911233 | benign | Hereditary cancer-predisposing syndrome | 2016-08-08 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000031425 | SCV001139064 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001392166 | SCV001593805 | likely benign | Hereditary breast ovarian cancer syndrome | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000217936 | SCV002533802 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-17 | criteria provided, single submitter | curation | |
University of Washington Department of Laboratory Medicine, |
RCV000217936 | SCV003846665 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |
All of Us Research Program, |
RCV000031425 | SCV004845175 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Sharing Clinical Reports Project |
RCV000031425 | SCV000054030 | benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2010-01-26 | no assertion criteria provided | clinical testing | |
Breast Cancer Information Core |
RCV000031425 | SCV000146247 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2004-02-20 | no assertion criteria provided | clinical testing | |
Department of Medical and Surgical Sciences, |
RCV000031425 | SCV004228394 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2023-09-01 | no assertion criteria provided | clinical testing | PP4(Moderate)+BS3(Strong)+BP1(Strong) according to ACMG/AMP classification guidelines specified for BRCA1 & BRCA2 (Classification Criteria V1.0.0 2023-09-08 - https://cspec.genome.network/cspec/ui/svi/affiliation/50087) (PMID: 38160042) |
BRCAlab, |
RCV000031425 | SCV004243606 | uncertain significance | Breast-ovarian cancer, familial, susceptibility to, 2 | 2020-03-02 | no assertion criteria provided | clinical testing |